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The murine nectin1a (mNectin1a), a homolog of human nectin1a (hNectin1a, or PRR1, HveC), mediates the entry of herpes
simplex virus (HSV) into cells. Previously, we reported that the binding of hNectin1 to HSV glycoprotein D (gD) was readily
detectable, whereas the binding of mNectin1 to gD was not detectable, thus raising the question whether mNectin1 mediates
a gD-dependent or a gD-independent pathway of entry. Here we report comparative binding studies of murine- and
human-nectin1a to virions and to gD. The assays consistently showed either a very weak binding or no detectable binding
of murine nectin1a to gD. They included (i) binding of soluble mNectin1-Fc or hNectin1-Fc to virions and competition of the
binding by soluble gD(D290–299t) and by monoclonal antibodies to gD; (ii) pull-down experiments of wt gD from lysates of
infected cells; and (iii) ELISA binding of soluble gD(D290–299t) to cells expressing mNectin1 or hNectin1. In contrast to the
binding studies, the entry studies readily showed that entry mediated by mNectin1 was dependent on gD. Thus, a gDnull
(gD2/2) mutant virus was unable to enter mNectin1-expressing cells, and entry of wild-type virus was inhibited by antibodies
to gD or soluble gD at similar concentrations. We infer that gD represents a weak ligand in the interaction between mNectin1
and virions, whereas it represents a strong and the major ligand for hNectin1. Yet gD is required in HSV-1 entry mediated by
mNectin1a. We conclude that a high-affinity binding of the receptor to gD is not a requirement in the gD-dependent pathway
of HSV entry to cells. © 2001 Academic PressINTRODUCTION
After the initial attachment to heparan sulfate glycos-
aminoglycans, herpes simplex virus (HSV) enters cells
through the interaction with one entry receptor (for re-
views, see Campadelli-Fiume et al., 2000; Campadelli-
Fiume, 2000; Spear et al., 2000). The human entry recep-
tors known to date belong to three unrelated molecular
families. All of them bind the virion envelope glycoprotein
D (gD) with a strong interaction. They are herpesvirus
entry mediator A (HveA), a member of the tumor necrosis
factor receptor family (Montgomery et al., 1996), the
members of the nectin family (Cocchi et al., 1998; Eberle´
et al., 1995; Geraghty et al., 1998; Lopez et al., 1995;
arner et al., 1998), and 3-O-sulfated heparan sulfate
Shukla et al., 1999). The human members of the nectin
amily are the human nectin1 (hNectin1) a and b (CD111),
wo splice variant isoforms with a common ectodomain
Cocchi et al., 1998; Geraghty et al., 1998; Lopez et al.,
995), the hNectin2a and -d (CD112), and also two splice
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256variant isoforms with a common ectodomain (Eberle´ et
al., 1995). The former are also known as HIgR and HveC,
the latter as HveB. The past and present designation of
the different nectin1 isoforms is summarized in Table 1.
The human nectin3 does not appear to act as HSV
receptor (Reymond et al., 2000). Structurally, they belong
to the immunoglobulin superfamily and are homologs of
the poliovirus receptor (CD155). hNectin1a and hNec-
tin1b mediate entry of all the HSV-1 and -2 strains tested,
mediate cell-to-cell transmission of virus, and are
broadly expressed in human cell lines and human tis-
sues (Cocchi et al., 2000, 1998; Geraghty et al., 1998). By
contrast, hNectin2a and hNectin2d mediate entry of mu-
tants carrying substitutions in gD at residues 25–27, but
not of wild-type HSV-1 (Lopez et al., 2000; Warner et al.,
1998). A feature of the human nectin-type molecules is
the promiscuous receptor activity for the animal alpha-
herpesviruses, pseudorabies virus (PrV), and bovine her-
pesvirus 1 (BHV-1) (Cocchi et al., 1998; Geraghty et al.,
1998; Nixdorf et al., 1999). The murine homolog of hNec-
tin1a (mNectin1a) serves as entry mediator for HSV-1,
HSV-2, PrV, and BHV-1 and therefore serves the same
range of viruses as its human counterpart (Menotti et al.,
2000; Shukla et al., 2000). By contrast with its human
counterpart, initial binding studies of mNectin1a failed to
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257MURINE AND HUMAN NECTIN1 BINDING TO HSV GLYCOPROTEIN Dshow a detectable binding activity to gD (Menotti et al.,
2000). In addition, cotransfection of mNectin1a cDNA
and gD gene failed to restrict HSV infection, whereas
cotransfection of hNectin1 cDNA and gD gene is known
to restrict infection, as a consequence of the ability of gD
to bind, and sequester the receptor (Campadelli-Fiume
et al., 1988; Geraghty et al., 2000).
All three types of human entry receptors known to date
interact strongly with gD (in the nanomolar to micromolar
range) (Krummenacher et al., 1999; Shukla et al., 1999;
Willis et al., 1998), and, at the same time, mediate a
gD-dependent pathway of entry. The question then arose
whether mNectin1 mediates a gD-dependent or a gD-
independent pathway of entry and whether the binding
pattern of mNectin1 to virions differs from that of hNec-
tin1 to virions. Examples of gD-independent pathways of
entry exist among the alphaherpesviruses (Schmidt et
al., 1994; Schroder et al., 1997).
To address these questions, here we focused on com-
parative binding and entry properties of mNectin1 and
hNectin1. The binding assays included (i) binding of
soluble mNectin1-Fc or hNectin1-Fc to virions and com-
petition of the binding by soluble gD(D290–299t) and by
monoclonal antibodies to gD; (ii) pull-down experiments
of wt gD from lysates of infected cells; and (iii) ELISA
binding of soluble gD(D290–299t) to cells expressing
mNectin1 or hNectin1. All assays consistently showed
either very weak or no detectable binding. In contrast to
the binding studies, the entry studies readily showed that
a gDnull (gD2/2) mutant virus was unable to enter
mNectin1a-expressing cells and that entry mediated by
Nectin1a was blocked by soluble gD and by monoclo-
al antibodies to gD at similar concentrations as entry
ediated by hNectin1. We infer that a strong interaction
TABLE 1
Past and Present Nomenclature of Nectin1 Isoforms
Present Past
Nectin1a, (human and murine)a PRR1
HveC
Nectin1d in refs. Cocchi et al., 2000;
Campadelli-Fiume et al., 2000;
Lopez et al., 2000; Menotti et al.,
2000
Nectin1b (human) HlgR
Nectin1a in refs. Cocchi et al., 2000;
Campadelli-Fiume et al., 2000;
Lopez et al., 2000; Menotti et al.,
2000.
a For murine nectin1, only the a isoform is known.f gD with the receptor is not a requirement in order for
SV to enter a cell.RESULTS
omparative binding of mNectin1 and hNectin1 to
irions
Previously, we described a quantitative binding assay
etween a soluble form of mNectin1a, mNectin1-Fc, and
HSV in which gradient-purified virions, immobilized onto
96 wells, were reacted with increasing concentrations of
purified mNectin1-Fc (Menotti et al., 2000). Here, we
made use of this quantitative binding assay to compare
the binding properties of murine and human nectin1 and
specifically asked whether the binding of mNectin1-Fc to
virions is blocked by soluble gD, monoclonal antibodies
(MAbs) to gD, and monoclonal antibodies to gB and gH.
A large body of evidence indicates that the monoclonal
antibodies which neutralize HSV infectivity in a comple-
ment-independent manner are directed to these three
glycoproteins, while monoclonal antibodies to gL do not
neutralize infectivity (Campadelli-Fiume et al., 2000;
Spear et al., 2000). The gradient-purified recombinant
virus R7032, which lacks gE and gI, two glycoproteins
with Fc-receptor binding activity, was employed to avoid
the binding of the Fc portion of the soluble receptors and
antibodies to virions. Binding of hNectin1-Fc and hNec-
tin2-Fc was analyzed in parallel. The binding to fetuin, a
soluble glycoprotein carrying oligosaccharides of the
type present in gD (Serafini-Cessi et al., 1988), gave an
estimate of the background level. The dose-dependent
binding curve of purified mNectin-Fc and hNectin-Fc to
purified virions immobilized onto 96 wells (Fig. 1A)
showed two major differences. First, the binding curve of
mNectin-Fc did not reach a plateau, whereas the binding
curve of hNectin1-Fc did reach a plateau at 14 nM hNec-
tin-Fc, in accordance with a previous report (Menotti et
al., 2000). Second, the binding of a comparable amount
of virions required about a 250-fold higher concentration
of the mNectin1-Fc relative to hNectin1-Fc. The binding
of mNectin1-Fc was significantly higher than that of
hNectin2-Fc to virions, or that between the soluble me-
diators and fetuin, taken as background values. The
lower binding activity of mNectin-Fc relative to hNec-
tin1-Fc did not reflect partial inactivation of virions in-
duced by their immobilization to the wells since a differ-
ent binding pattern of mNectin-Fc or hNectin-Fc to virions
was observed also when the test was performed in the
reverse manner, i.e., by immobilizing the soluble recep-
tors, followed by binding of increasing amounts of puri-
fied virions (Fig. 1B). Figure 1C shows the purity of the
affinity-purified mNectin1-Fc, hNectin1-Fc, and hNec-
tin2-Fc preparations. All preparations displayed equal
inhibitory activity on R8102 entry into mNectin1- and
hNectin1-expressing cells (data not shown).
The effect of antibodies to gD, gB, and gH on the
binding of mNectin1-Fc to virions is illustrated in Fig. 1D.
The binding was only slightly reduced by preincubation
.258 MENOTTI ET AL.of virions with monoclonal antibodies to gD (HD1, III
114–4) at antibody concentrations that practically abol-
FIG. 1. Binding characteristics of purified soluble mNectin1-Fc o
gradient-purified R7032 virions, immobilized onto the wells, were a
mNectin1-Fc (mNec1-Fc) or hNectin1-Fc (hNec1-Fc). Binding of hNecti
fetuin gave an estimate of background reactivity. (B) Binding of increas
hNectin2-Fc or BSA as control (each at 0.75 mg/well). (C) Coomassie
hNectin1-Fc 5 mg, hNectin2-Fc 2 mg. The figures to the left represent th
of monoclonal antibodies directed to gD (HD1, III 114–4, H170), to
gradient-purified R7032 virions of mNectin1-Fc (125 nM) (D), or hNecti
IgGs. Neutralizing monoclonal antibodies to gD completely inhibit the
virions. The concentration of hNectin1-Fc (5 nM (l), or 125 nM (f)) did
on the binding of mNectin1-Fc or hNectin1-Fc to R7032 virions. In A, D
anti-human IgG peroxidase-conjugated antibody. In B, binding of virion
triplicates. The standard error ranged from 0.6 to 1.9% of mean valuesished the binding of hNectin-Fc to virions (Fig. 1E). In
these competition curves, the concentration of mNec-tin1-Fc and hNectin1-Fc were 125 and 5 nM, respectively
(i.e., the minimal hNectin1-Fc concentration that gave the
tin1-Fc to gradient-purified R7032 virions. (A) 6 3 107 PFU/well of
to react with increasing concentrations of soluble affinity-purified
Nec2-Fc) to virions and binding of the soluble nectins to immobilized
unts of R7032 virions to immobilized mNectin1-Fc or hNectin1-Fc and
aining of the affinity-purified soluble receptors: mNectin1-Fc 5 32 mg,
rophoretic mobility of molecular weight markers (MW). (D and E) Effect
26 and H233), and to gH (52S), or mouse IgGs, on the binding to
5 nM, except when otherwise stated) (E). All antibodies were purified
g of hNectin-Fc, but only slightly affect the binding of mNectin-Fc to
nge the competition curve of HD1. (F) Effect of purified gD(D290–299t)
d F, binding of mNectin-Fc or hNectin1-Fc was detected by means of
revealed by anti-gC MAb HC1. Each point represents the average ofr hNec
llowed
n2-Fc (h
ing amo
blue st
e elect
gB (H1
n1-Fc (
bindin
not cha
, E, an
s washighest binding, see Fig. 1A). When the concentration of
hNectin1-Fc was brought to 125 nM, the inhibition curve
indicat
, 10, 15
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hNectin1-Fc. The monoclonal antibodies to gB (H126 and
H233) (Pereira et al., 1981), and gH (52S) (Showalter et al.,
1981) had no effect on the binding of either receptor to
virions. The effect of purified soluble gD(D290–299t) on
the binding to virions of mNectin1-Fc or hNectin1-Fc
(both at 125 nM) is shown in Fig. 1F. gD(D290–299t)
represents a recombinant form with a deletion between
residues 290 and 299, and, for unexplained reasons,
binds the human HSV receptors with about 100-fold
higher affinity than gD(306t) (Krummenacher et al., 1998).
Soluble gD(D290–299t) competed with the binding of
both mNectin1-Fc and hNectin1-Fc to gradient-purified
R7032 virions immobilized onto 96-well trays. The inhibi-
tion curves were almost overlapping. We conclude the
following. (i) The binding of mNectin1-Fc to virions differs
greatly from the binding of hNectin1-Fc to virions. The
binding of mNectin1-Fc was not saturable under the
assay conditions, i.e., up to a concentration 20-fold
higher than that required for plateau binding of hNec-
tin1-Fc to virions. (ii) A role of gD could be revealed when
the binding of mNectin1-Fc to virions was competitively
reduced by soluble gD(D290–299t). (iii) The binding of
hNectin1-Fc to virions is saturable in the assay condi-
tions used, and gD represents a major and strong ligand
in it. (iv) Previously, we failed to detect a significant
binding of gD(D290–299t) to cells expressing mNectin1
by fluorescence microscopy (Menotti et al., 2000). The
apparent discrepancy with the inhibition exerted by
gD(D290–299t) on the binding of mNectin1-Fc to virions
FIG. 2. Precipitation of viral proteins by mNectin1-Fc (mNec1) or hN
the purified soluble receptors from lysates of 35S-methionine- and cyste
The corresponding immunoblot with anti-gD MAb H170. (C) Autoradiog
(52S), gB (H233), and gD (HD1) from lysates of 35S-methionine- and cys
proteins precipitated by the purified soluble receptors from lysates of
immunoblot with anti-gD MAb H170. Figures to the left of A indic
electrophoretic mobility of the viral glycoproteins gH, gB, and gD is
glycoprotein (lanes 2, 5, 11, 16); hNectin1-Fc pulls down gD (lanes 1, 4may reflect a low-binding activity of mNectin1 to gD
coupled with different sensitivities of the assays.mNectin1 fails to pull-down gD
To further characterize the interaction of mNectin1
with virion proteins, we tested whether mNectin1-Fc or
hNectin1-Fc can pull down viral proteins, including the
glycoproteins gD, gB and gH, from lysates of HSV-in-
fected cells. Lysates of 143TK- cells infected with R7032,
or of a 143-derived cell line expressing constitutively gD,
labeled with 35S-methionine and cysteine, were reacted
with mNectin1-Fc or hNectin1-Fc. The complexes were
harvested with Protein A–Sepharose (Figs. 2A, 2B, 2D,
and 2E). A radioimmunoprecipitation with MAbs to gH
(52S), gB (H233), and gD (HD1) was performed in parallel
to determine the electrophoretic mobility of the glyco-
proteins (Fig. 2C). mNectin1-Fc failed to pull down any
viral protein, while hNectin1-Fc readily pulled down a
protein with the electrophoretic mobility of gD (compare
lanes 1, 3, and 9). The protein was indeed gD, as as-
sessed with the cell line expressing gD (Fig. 2D, lanes 10
and 12), and by blotting the electrophoretically separated
proteins with monoclonal antibody H170 directed to gD
(Pereira et al., 1982) (Fig. 2E, lanes 15 and 17). The faint
band visible in lane 16 does not correspond to gD, as it
is visible also in the lysate from the parental 143TK- cell
line not expressing gD (lane 18).
Comparative binding of mNectin1 and hNectin1 to gD
Previously, using a fluorescence assay, we were un-
able to detect a significant binding of biotinylated
gD(D290–299t) to cells which express mNectina (Menotti
et al., 2000). Here, we performed a quantitative binding
c (hNec1). (A) Autoradiographic image of the proteins precipitated by
led (35S-Met) R7032-infected cells and transferred to nitrocellulose. (B)
image of the immunoprecipitation of gD, gB, and gH with MAbs to gH
beled R7032-infected 143TK- cells. (D) Autoradiographic image of the
pressing cell line or the parental 143 cell line. (E) The corresponding
e electrophoretic mobility of molecular weight markers (MW). The
ed with black arrowheads. mNectin1-Fc fails to pull down any viral
).ectin1-F
ine-labe
raphic
teine-la
a gD-ex
ate thassay by measuring the binding of biotinylated gD(D290–
299t) (Nicola et al., 1997) to cells which express mNec-
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260 MENOTTI ET AL.tin1a or hNectin1b or to the parental J cells, which do not
xpress any mediator of HSV entry (Cocchi et al., 1998).
s a measure of the binding specificity, the same cells
ere also reacted with an unrelated biotinylated glyco-
rotein, fetuin. Cells were fixed with paraformaldehyde
Fig. 3A) or methanol (Fig. 3B). The results in Fig. 3 show
hat cells which express mNectin1a did not bind gD to a
level significantly higher than that seen in J cells, or in the
mNectin1a cells reacted with fetuin. The binding of cells
hat express hNectin1b to gD showed a dose-dependent
attern and was readily detectable at gD concentration
n the 10-nM range. In Fig. 3C we ascertained that bio-
inylation of gD(D290–299t) did not adversely affect its
inding activity. To this end, the binding of hNectin1-Fc to
mmobilized gD(D290–299t) was competed by native
D(D290–299t) or by biotinylated gD(D290–299t). The
competition curves of biotinylated and nonbiotinylated
gDs paralleled closely, ruling out that biotinylation exerts
a major denaturing effect on gD.
Some assays, e.g., the competition assay described in
Fig. 1, and the cell–ELISA binding illustrated in Fig. 3,
necessarily require the use of a recombinant soluble
form of gD. Other assays, e.g., the pull-down experiment
shown in Fig.2 and direct binding assays, can be per-
FIG. 3. Binding of biotinylated gD(D290–299t) to stable transformants
Cells fixed with paraformaldehyde and permeabilized with Triton X-10
concentrations of biotinylated gD(D290–299t) or biotinylated fetuin as
followed by o-phenylenediamine. Each point represents the average o
Increasing concentrations of biotinylated or native gD(D290–299t) were
immobilized gD(D290–299t). Each point represents the average of tripl
seen that either biotinylated or native gD(D290–299t) competed equallformed with wt transmembrane gD from infected cells. It
was thus of interest to compare the binding activity of
a
emNectin1-Fc and of hNectin1-Fc to the various forms of
gD employed in the in different assays. Figure 4 illus-
trates the dose-dependent binding curves of mNec-
tin1-Fc and hNectin1-Fc to wt gD (A), gD(D290–299t) (B),
or gD(306t) (not shown). All forms of gD were affinity
purified to homogeneity. Each glycoprotein was immobi-
lized onto 96 wells at the input concentration of 600
ng/well. Color was developed after 12 min for wt gD and
80 min for gD(D290–299t). It can be noted that binding to
wt gD was overall more readily detectable than the
binding to gD(D290–299t). The binding to gD(306t) was
low (below 0.1 OD), and it could not be taken into con-
sideration, even allowing 120 min for color development.
With either wt gD or gD(D290–299t) the binding of mNec-
tin1-Fc was weak, but detectable, and required about
250-fold higher concentration of mNectin1-Fc than of
hNectin1-Fc (150 versus 0.62 nM). Binding of mNec-
tin1-Fc to gD(306t), as reported by another laboratory,
was detected at about 30-fold higher mNectin1-Fc con-
centration (5 mM) (Shukla et al., 2000). Previously, by
mmobilizing 80 ng of wt gD we were unable to detect
ny binding of mNectin1-Fc to wt gD (Menotti et al.,
000). We infer from this type of experiments that the
orm and amount of gD employed greatly influences the
lls expressing mNectin1a, hNectin1b, or to the parental J cell line. (A)
ells fixed with methanol. Cells were allowed to react with increasing
l. Binding was detected by means of avidin-conjugated peroxidase,
ates. (C) Biotinylation does not affect gD(D290–299t) binding activity.
with a fixed amount of hNectin1-Fc (125 nM) and allowed to react with
The standard error ranged from 0.7 to 2.2% of mean values. It can be
Nectin1-Fc binding.of J ce
0. (B) C
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icates.bility to detect a binding activity, as shown also in
arlier studies with the human receptors (Krummenacher
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261MURINE AND HUMAN NECTIN1 BINDING TO HSV GLYCOPROTEIN Det al., 1998). Independent of this, and consistent with all
the above data, the binding of mNectin1-Fc is much
weaker than the binding of hNectin1-Fc. We also note
that, while the binding activity of hNectin1 is readily
detected under any assay condition used, the binding of
mNectin1 is so weak that, in some assay conditions, it is
not or is barely detectable.
mNectin1 fails to mediate entry of HSV virions
lacking gD
The following experiments were designed to investi-
gate whether gD is required for the HSV entry mediated
by mNectin1. As a first approach, we assessed whether
virions devoid of gD can enter cells which express
mNectin1a. The gD2 mutant FgD-b (Ligas and Johnson,
1988) was grown in noncomplementing cells to obtain a
gDnull virus (gD2/2). To have an approximate estimate
of the quantity of virions, aliquots of the purified extra-
cellular virions were separated by PAGE and compared
to extracellular virions of HSV-1(F) by means of Coomas-
sie blue staining. mNectin1a-expressing cells were ex-
osed to increasing amounts of FgDb(gD2/2) or R8102
virions. Both recombinant viruses carry a LacZ gene
driven by a HSV promoter, and entry into cells is quan-
titatively monitored as b-galactosidase activity (Cocchi et
al., 1998; Montgomery et al., 1996). As shown in Fig. 5,
FIG. 4. Binding of mNectin1-Fc and hNectin1-Fc to wild-type gD (A),
or gD(D290–299t) (B). The indicated gDs were immobilized onto 96
wells, at input concentration of 600 ng/well, and allowed to react with
increasing concentrations of soluble mNectin1 (mNec-Fc) or hNectin1
(hNec-Fc). The binding was revealed with anti-human IgG peroxidase,
followed by o-phenylenediamine. Color development was stopped after
2 and 80 min for wt gD and gD(D290–299t), respectively. Each point
epresents the average of triplicates. The standard error ranged from
.5 to 2% of the mean values.FgDb(gD2/2) failed to enter mNectin1a-expressing
cells. As a control, the gD-complemented FgDb(gD2/1)readily infected the cells expressing hNectin1b cells
(data not shown). These results provide a first line of
evidence that gD does play a role in the entry process
mediated by mNectin1a.
Soluble gD and monoclonal antibodies to gD block
entry mediated by mNectin1a
To investigate further the role of gD in HSV entry
mediated by mNectin1a, we assessed whether infectivity
in mNectin1a-expressing cells is blocked by soluble
gD(D290–299t) or by monoclonal antibodies to gD. In the
first assay, cells expressing mNectin1a or hNectin1b
were incubated with increasing concentrations of
gD(D290–299t) and then infected with R8102. The results
in Figs. 6A and 6B show that gD(D290–299t) blocked HSV
infectivity in both mNectin1a- and hNectin1b-expressing
cells with a very similar pattern. In the second assay,
R8102 virions were preincubated with purified IgGs from
MAbs HD1, III 114–4, H170, AP7, or control mouse IgGs,
and then allowed to infect mNectin1a- or hNectin1b-
xpressing cells. The results in Figs. 6C and 6D show
hat virus entry was blocked by MAbs to gD in a dose-
ependent manner. For three antibodies, namely HD1, III
14–4, and H170, the inhibition curves were similar in
Nectina- and hNectin1b-expressing cells. One anti-
body, MAb AP7, inhibited infectivity in mNectin1a-ex-
ressing cells, but not in cells expressing hNectin1b.
his antibody recognizes a discontinuous epitope whose
oundaries are not well defined, and it fails to react with
D(D290–299t) (our unpublished results). In the last se-
ies of experiments we tested whether infectivity in
Nectin1a-expressing cells is sensitive to inhibition by
onoclonal antibodies to gB (H233 and H126) and gH
52S), which are known to block HSV infectivity in a
umber of cell lines. MAbs H233, H126, and 52S blocked
FIG. 5. Lack of infectivity of the gD-minus virus FgD-b (gD2/2) for
Nectin1a- or hNectin1b-expressing J cells. The two cell lines, grown
n 96 wells, were exposed to increasing amounts of FgD-b virus grown
n noncomplementing cells (gD2/2) or R8102 (approximate m.o.i. from
to 32 PFU or PFU equivalents/cell). Infection was monitored as
b-galactosidase activity. Each bar represents the average of triplicates.
The standard error ranged from 0.5 to 2.2% of the mean values.
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262 MENOTTI ET AL.HSV infectivity in both mNectin1- or hNectin1-expressing
cells in a dose-dependent manner and with similar
curves (data not shown). Altogether the results indicate
that (i) HSV infectivity in mNectin1a-expressing cells can
be blocked by soluble gD(D290–299t) and by monoclonal
antibodies to gD; (ii) the inhibitory concentrations were
similar; (iii) the anti-gD monoclonal antibodies with po-
tent neutralizing activity can block infectivity in cells
expressing either the murine or the human receptor; (iv)
one monoclonal antibody to gD had a differential effect in
the two cell types, suggesting that part of the epitope
recognized by this antibody participates in the entry
mediated by mNectin1a, but not in entry mediated by
FIG. 6. Block of R8102 infectivity by gD(D290–299t) (A and B) or
monoclonal antibodies directed to gD (C and D) in cells expressing
mNectin1a (A and C) or hNectin1b (B and D). In A and B, cells grown
in 96 wells were preincubated with increasing concentrations of
gD(D290–299t) and then infected with R8102. In C and D, a fixed
amount of R8102 virions (5 PFU/cell) was preincubated with increasing
concentrations of purified IgGs from the indicated monoclonal antibod-
ies or mouse IgGs for 1 h at 37°C and then allowed to infect cells.
Infection was monitored as b-galactosidase activity. Each point repre-
ents the average of triplicates. The standard error ranged from 0.6 to
.1% of the mean values.hNectin1b; and (v) monoclonal antibodies to gB and gH
an block infectivity in both cell lines.
a
eDISCUSSION
The three known human receptors that mediate HSV
ntry into cells bind gD with strong interaction and me-
iate a gD-dependent pathway of entry (see Campadelli-
iume et al., 2000; Campadelli-Fiume, 2000; Spear et al.,
2000). Previously, we showed that mNectin1 mediates
HSV entry but failed to detect a measurable gD-binding
activity, thus raising the issue of whether entry mediated
by mNectin1 is dependent on or independent of gD.
Here, we have performed a detailed comparison be-
tween murine and human nectin1 binding activity to
virions and to gD. Cumulatively, these studies show that
the binding pattern of mNectin1 to virions and to gD
differs greatly from the corresponding binding pattern of
hNectin1 and that gD represents a weak ligand for
mNectin1, whereas it does represent a strong and the
major ligand for hNectin1. We further show here that
entry mediated by mNectin1a requires gD. Current stud-
es lead to the conclusion that a strong interaction of
irion gD with the entry receptor is not a requirement for
SV to enter a cell. Such conclusion was not foreseen in
tudies of the human receptors for HSV entry (see Cam-
adelli-Fiume et al., 2000; Spear et al., 2000). We discuss
hese conclusions separately below.
While this paper was under revision, a report was
ublished on two allelic isoforms of murine nectin1a,
ne slightly different from the present one (allele FVB/N)
nd one with the same sequence as the present one
allele C3H) (Shukla et al., 2000). The two allelic isoforms
ere indistinguishable with respect to binding activity to
D. Binding was seen for both allelic forms only at 10 mM
gD concentration (Shukla et al., 2000). Hence, it appears
that the differences between murine and human receptor
reported here hold true for both allelic forms. Compari-
son of the binding pattern of mNectin1 and hNectin1 was
not investigated in that report, nor was the gD-depen-
dency of the murine Nectin1a-mediated entry. A discrep-
ncy between the two studies concerned the effect of
oexpression of mNectin1 and gD, which in our former
tudy failed to block HSV infectivity (Menotti et al., 2000),
hereas in the latter study it induced a block of HSV
nfectivity (Shukla et al., 2000). A block in infectivity of wt
SV (but not of mutants carrying substitutions in gD at
esidues 25–27, which abolish the interaction with hNec-
in1) is readily seen when hNectin1 is coexpressed with
t gD (Brandimarti et al., 1994; Campadelli-Fiume et al.,
990; Geraghty et al., 2000). The reason for the discrep-
ncy is unclear at the moment.
inding of mNectin1 to virions and the role of gD
In this study we compared the interaction of soluble
Nectin1-Fc and of hNectin1-Fc with virions by means of
quantitative ELISA-based binding assay and pull-down
xperiments. The assays showed the following. (a) The
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263MURINE AND HUMAN NECTIN1 BINDING TO HSV GLYCOPROTEIN Ddose-response binding curve of mNectin1-Fc to virions
differed significantly from the curve of hNectin1-Fc to
virions. It occurred at about 250-fold higher mNectin1-Fc
concentration and did not reach a plateau (Fig. 1A). (b)
The binding was only slightly affected by monoclonal
antibodies to gD at concentrations which abolish the
binding of hNectin1-Fc to virions (Figs. 1D and 1E). (c)
The binding was however competed by soluble gD (Fig.
1F). These results highlight a significant difference in the
binding pattern of mNectin1 and hNectin1 to virions.
The direct binding of hNectin1 to gD has been readily
detectable and well documented in studies from different
laboratories, including our laboratory. When the interac-
tion of mNectin1 with gD has been investigated under
the same conditions, and with similar constructs, a num-
ber of assays showed a weak binding activity or failed to
show any evidence of detectable binding. To summarize
present and past evidence, a direct binding, albeit weak,
has been detected between mNectin1-Fc and wt gD or
soluble gD(D290–299t) by increasing the amount of gD
immobilized to wells (Fig. 4). On the other hand, evidence
of binding could not be detected in pull-down experi-
ments (Fig. 2), in cotransfection experiments of mNectin1
and gD (Menotti et al., 2000), nor in cell–ELISA (Figs. 3A
and 3B). Thus, previous and current analyses cumula-
tively point to a notable difference in the binding pattern
of mNectin1 and hNectin1 to gD. gD appears to repre-
sent a weak ligand for mNectin1, whereas it represents a
major and strong ligand for hNectin1.
Entry mediated by mNectin1 requires gD
While the binding studies of mNectin1 to gD failed to
show a strong interaction, two series of experiments
unambiguously showed that entry mediated by mNectin1
requires gD. First, a gD2/2 virus was unable to enter
ells expressing mNectin1a (Fig. 5). Second, entry me-
diated by mNectin1a was inhibited by soluble gD and by
Abs to gD at similar concentrations as entry mediated
y hNectin (Fig. 6). The current studies support the view
hat gD does play a key role in entry mediated by mNec-
in1a. Two possibilities are foreseen. In one case, the
ole of gD in the entry mediated by mNectin1 is totally
ccounted for by the weak ligand activity, which is suffi-
ient to trigger the fusion event carried out by gB and
H/gL. Probably this occurs through conformational
hanges induced in gD following the binding to the
eceptor, which, in turn, favors the recruitment of gB and
H/gL. This conclusion appears to be in contrast with the
bservation that entry was inhibited by soluble gD and
y antibodies to gD at similar concentrations in mNec-
in1 or hNectin1 cells, yet the concentrations of antibod-
es to gD which abolished entry via mNectin1 only
lightly affected the binding of mNectin1 to virions. The
econd possibility is that gD itself participates in theusion event between virion envelope and plasma mem-
rane as part of a putative fusion complex made of gD,
B, and gH-gL (see Campadelli-Fiume et al., 2000). The
inding that MAbs to gB and gH block infection mediated
y mNectin1 (not shown) highlight the roles of these two
lycoproteins in mNectin1a-mediated entry, but does not
allow us to discriminate between the two hypotheses.
The possibility that gD itself participates in the fusion
event is in accordance with a number of indirect obser-
vations that suggest that gD may encode different func-
tional domains and activities and that its role in HSV
entry may not be fully accounted for by its receptor-
binding activity (Fuller and Spear, 1985; Krummenacher
et al., 1998; Noble et al., 1983; Whitbeck et al., 1999).
The novelty of the observations reported here stems
from the conclusion that a high-affinity interaction of gD
to the receptor, a hallmark of the entry process mediated
by the human receptors, is not a requirement in the
gD-dependent pathway of HSV entry into the cell. Ulti-
mate elucidation of the role played by gD in the HSV
entry rests on mutational analysis. The availability of two
receptors with different gD-binding activities and differ-
ences in primary sequences provides a rationale for the
mutagenesis design.
MATERIALS AND METHODS
Binding of soluble mNectin1-Fc and hNectin1-Fc to
HSV virions
Extracellular R7032 (Meignier et al., 1988) virions were
gradient purified as described (Krummenacher et al.,
1998), immobilized onto 96 wells (6 3 107 PFU/well) in
bicarbonate buffer (15 mM Na2CO3, 35 mM NaHCO3,
0.02% NaN3, pH 9.5) at 4°C overnight (Lopez et al., 2000),
locked for 2 h at 37°C with 2% BSA in PBS, and allowed
o react with increasing concentrations of soluble mNec-
in1-Fc, hNectin1-Fc, or hNectin2-Fc, in 1% BSA, 2% NaCl
n PBS for 2 h at 37°C. The soluble receptors were
onstructed and affinity-purified as described (Cocchi et
l., 1998; Menotti et al., 2000). Binding of soluble recep-
ors was revealed by anti-human IgG peroxidase-conju-
ated antibody (Dako A/S, Denmark), followed by o-
henylenediamine (Sigma Chemical Co., Milan) as sub-
trate, and monitoring at 490 nm. In experiments where
he binding was performed in the reverse manner, 0.75
mg/well of purified mNectin1-Fc or hNectin1-Fc was im-
mobilized onto 96 wells in bicarbonate buffer (15 mM Na2
CO3, 35 mM NaHCO3, 0.02% NaN3, pH 9.5), blocked for
2 h at 37°C with 2% BSA in PBS, and incubated with
increasing amounts of gradient-purified R7032 virions for
2 h at 37°C. Binding was detected by means of antigly-
coprotein C MAb HC1 (Pereira et al., 1980), followed by
anti-mouse IgG peroxidase-conjugated antibody (Sigma)
and o-phenylenediamine. For competition experiments,
replicate aliquots of gradient-purified R7032 virions (6 3
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264 MENOTTI ET AL.107 PFU/well), immobilized onto 96 wells, were incubated
ith increasing concentrations of purified IgGs from the
ndicated antibodies in 1% BSA 2% NaCl in PBS for 2 h at
7°C and allowed to bind a fixed amount of purified
oluble receptors for a further 2 h at 37°C. The amounts
ere 125 nM for mNectin1-Fc and 5 nM for hNectin1-Fc
corresponding to the minimal concentration that gave
he maximum binding). The competition with MAb HD1
as performed at both 5 and 125 nM hNectin1-Fc. To
etermine the effect of gD(D290–299t) (Nicola et al.,
997), immobilized gradient-purified virions were allowed
o react with mNectin1-Fc or hNectin1-Fc at 125 nM in
he presence of increasing concentrations of gD(D290–
99t) or fetuin.
The concentration of affinity-purified soluble recep-
or-Fc was determined using the method of Lowry (Lowry
t al., 1951). The purity of the preparations was checked
y SDS–PAGE separation and Coomassie blue staining.
very batch of purified receptor-Fc was also checked for
ts inhibitory activity in infectivity blocking assays.
inding of soluble mNectin1-Fc and hNectin1-Fc
o gD
Ninety-six wells were coated with 600 ng/well of affin-
ty-purified wild-type gD (Lopez et al., 2000), gD(D290–
99t), or gD(306t) in Na-bicarbonate buffer at 4°C over-
ight, blocked with 2% BSA for 2 h at 37°C, and allowed
o react with increasing concentrations of purified solu-
le receptors mNectin1-Fc and hNectin1-Fc in 1% BSA,
% NaCl in PBS for 2 h at 37°C. Binding was revealed by
nti-human IgG peroxidase-conjugated antibody, fol-
owed by o-phenylenediamine and monitoring at 490 nm.
he color development reaction was stopped at 12, 80,
nd 120 min for the wells coated with wt gD, gD(D290–
99t), and gD(306t), respectively.
ull-down and radioimmunoprecipitation assay
143TK- cells infected with the HSV recombinant R7032
ere labeled with 35S-methionine and cysteine from 5 to
4 h after infection. For construction of the cell line
xpressing constitutively gD, the gD ORF containing 14
p upstream the AUG codon and 32 bp downstream the
top codon was PCR amplified from HSV DNA and
loned into the pRPneoCMV vector (Sabbioni et al.,
995). The plasmid was transfected into 143TK- cells; the
ransformed cells were selected by means of neomycin
esistance and cloned. The gD-expressing cells and the
arental 143TK- cells were labeled with 35S-methionine
and cysteine for 19 h. All lysates were obtained in PBS
buffer containing 1% sodium deoxycholate, 1% Nonidet-
P40, 0.1 mg/ml TLCK (Na-p-tosyl-L-lysine choromethyl
etone), and 0.1 mg/ml TPCK (N-tosyl-L-phenylalanine
horomethyl ketone) and incubated for 1 h at 4°C with 1.5
mg of purified soluble receptors. The complexes were
s
nharvested with Protein A–Sepharose (Sigma), separated
by SDS–PAGE, and transferred onto a nitrocellulose
sheet. Radioactive bands were detected using a Bio-Rad
Molecular Imager. The nitrocellulose sheets were blot-
ted with anti gD MAb H170 (Pereira et al., 1982), followed
by anti-mouse biotinylated antibody and avidin-biotin-
peroxidase (Vector Laboratories) and diaminobenzidine
as substrate.
Binding of biotinylated gD(D290–299t) to cells
Stable transformants of J cells expressing mNectin1a
or hNectin1b (Cocchi et al., 1998; Menotti et al., 2000)
ere grown in 96-well trays, fixed with 1% paraformalde-
yde in PBS for 30 min, and permeabilized with 0.1%
riton X-100 for 10 min or, alternatively, fixed with meth-
nol for 10 min at 220°C. Fixed cells were blocked with
2% BSA in PBS for 2 h at 37°C and allowed to react with
increasing concentrations of biotinylated gD(D290–299t)
or fetuin as control in PBS containing 1% BSA for 60 min.
Biotinylation was carried out as described (Cocchi et al.,
1998). Biotinylated gD(D290–299t) was removed; mono-
layers were washed three times with PBS containing
0.1% Tween 20. Binding was revealed by avidin-conju-
gated peroxidase (Vector Laboratories), followed by o-
phenylenediamine and monitoring at 490 nm. To check
that biotinylation did not alter gD(D290–299t) binding
activity, a competitive ELISA was performed as follows.
Ninety-six wells were coated with 600 ng/well of
gD(D290–299t) in bicarbonate buffer (15 mM Na2 CO3, 35
mM NaHCO3, 0.02% NaN3, pH 9.5), then allowed to react
ith a fixed amount of purified hNectin1-Fc (125 nM) in
he presence of increasing concentrations of biotinylated
r native gD(D290–299t). Binding was revealed by means
f anti-human IgG peroxidase and o-phenylenediamine
nd monitoring at 490 nm.
nfectivity of gD2/2 virus
The gD2 FgD-b virus (Ligas and Johnson, 1988) was
rown in noncomplementing Vero cells (gD2/2). Since
his virus fails to form plaques in noncomplementing
ells, PFU equivalents were quantified by subjecting the
irus stock to electrophoresis, in parallel with titrated
mounts of purified HSV-1(F), followed by Coomassie
lue staining. mNectin1a- and hNectin1b-expressing J
cells grown on 96-well plates were infected with increas-
ing amounts of R8102, a HSV derivative carrying a LacZ
reporter gene under the alfa27 promoter (Cocchi et al.,
1998) and gD2/2 virus, as indicated. At 24 h.p.i. infected
cells were lysed with 100 ml/well PBS containing 0.5%
P-40 (Non-Idet P40) and 3 mg/ml ONPG (o-nitrophenyl-
b-D-galactopyranoside; Sigma). b-galactosidase expres-ion was quantified by reading the optical density at 405
m in a Bio-Rad Microplate Reader.
lM
265MURINE AND HUMAN NECTIN1 BINDING TO HSV GLYCOPROTEIN DInfectivity blocking assays
J cells expressing mNectin1a or hNectin1b grown in
96 wells were preincubated with increasing amounts of
gD(D290–299t) and then infected with R8102 (5 PFU/cell).
Infection was monitored as b-galactosidase activity 16 h
ater (Cocchi et al., 1998; Montgomery et al., 1996). For
infectivity block by MAbs to gD (HD1, H170, III 114–4,
AP7), a fixed amount of R8102 virions (5 PFU/cell) was
preincubated with increasing concentrations of purified
IgGs of the indicated monoclonal antibodies, or mouse
IgGs, for 1 h at 37°C and then allowed to infect cells. The
viral inoculum was removed and cells were overlaid with
medium containing the same concentrations of antibod-
ies. Infection was monitored as b-galactosidase activity
as described (Cocchi et al., 1998; Montgomery et al.,
1996).
ACKNOWLEDGMENTS
We thank Elisabetta Romagnoli for invaluable assistance with cell
cultures. We thank Dr. G. H. Cohen and Dr. R. Eisenberg (University of
Pennsylvania), Dr. D. Johnson (Oregon University), Dr. P. G. Spear
(Northwestern University), Dr. T. A. Minson (University of Cambridge),
and Dr. N. S. Markovitz and B. Roizman (University of Chicago) for
generous gifts of soluble gD(D290–299t) and gD(306t), FgDb virus, MAb
III 114–4, MAb AP7, and R8102. The work done at the University of
Bologna was supported by grants from CNR-Target Project in Biotech-
nology, Telethon Grant A141, MURST-progetti di interesse nazionale
40%, University of Bologna 60%, and pluriannual plan. The studies at
INSERM U119, Marseille, were aided by INSERM, the Association pour
la Re´cherche Contre le Cancer (ARC), and the Ligue Nationale Fran-
c¸aise Contre le Cancer (LNFCC).
REFERENCES
Brandimarti, R., Huang, T., Roizman, B., and Campadelli Fiume, G.
(1994). Mapping of herpes simplex virus 1 genes with mutations
which overcome host restrictions to infection. Proc. Natl. Acad. Sci.
USA 91(12), 5406–5410.
Campadelli-Fiume, G. (2000). Virus receptor arrays. CD46 and human
herpesvirus-6. Trends Microbiol. 8(10),436–438.
Campadelli-Fiume, G., Arsenakis, M., Farabegoli, F., and Roizman, B.
(1988). Entry of herpes simplex virus 1 in BJ cells that constitutively
express viral glycoprotein D is by endocytosis and results in degra-
dation of the virus. J. Virol. 62(1), 159–167.
Campadelli-Fiume, G., Cocchi, F., Menotti, L., and Lopez, M. (2000). The
novel receptors that mediate the entry of herpes simplex viruses and
animal alphaherpesviruses into cells. Rev. Med. Virol. 10(5), 305–319.
Campadelli-Fiume, G., Qi, S., Avitabile, E., Foa`-Tomasi, L., Brandimarti,
R., and Roizman, B. (1990). Glycoprotein D of herpes simplex virus
encodes a domain which precludes penetration of cells expressing
the glycoprotein by superinfecting herpes simplex virus. J. Virol.
64(12), 6070–6079.
Cocchi, F., Menotti, L., Dubreuil, P., Lopez, M., and Campadelli Fiume, G.
(2000). Cell-to-cell spread of wild type herpes simplex virus 1, but not
of syncytial strains, is mediated by the immunoglobulin-like recep-
tors that mediate virion entry, nectin1 (HveC/HIgR/PRR1) and nectin2
(PRR2). J. Virol. 74(8), 3909–3917.
Cocchi, F., Menotti, L., Mirandola, P., Lopez, M., and Campadelli-Fiume,
G. (1998). The ectodomain of a novel member of the immunoglobulin
superfamily related to the poliovirus receptor has the attibutes of abonafide receptor for herpes simplex viruses 1 and 2 in human cells.
J. Virol. 72, 9992–10002.
Eberle´, F., Dubreuil, P., Mattei, M. G., Devilard, E., and Lopez, M. (1995).
The human PRR2 gene, related to the human poliovirus receptor
gene (PVR), is the true homolog of the murine MPH gene. Gene
159(2), 267–272.
Fuller, A. O., and Spear, P. G. (1985). Specificities of monoclonal and
polyclonal antibodies that inhibit adsorption of herpes simplex virus
to cells and lack of inhibition by potent neutralizing antibodies.
J. Virol. 55(2), 475–482.
Geraghty, R. J., Jogger, C. R., and Spear, P. G. (2000). Cellular expression
of alphaherpesvirus gD interferes with entry of homologous and
heterologous alphaherpesviruses by blocking access to a shared gD
receptor. Virology 268(1), 147–158.
Geraghty, R. J., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., and
Spear, P. G. (1998). Entry of alphaherpesviruses mediated by polio-
virus receptor-related protein 1 and poliovirus receptor. Science
280(5369), 1618–1620.
Krummenacher, C., Nicola, A. V., Whitbeck, J. C., Lou, H., Hou, W.,
Lambris, J. D., Geraghty, R. J., Spear, P. G., Cohen, G. H., and Eisen-
berg, R. J. (1998). Herpes simplex virus glycoprotein D can bind to
poliovirus receptor-related protein 1 or herpesvirus entry mediator,
two structurally unrelated mediators of virus entry. J. Virol. 72(9),
7064–7074.
Krummenacher, C., Rux, A. H., Whitbeck, J. C., Ponce-de-Leon, M., Lou,
H., Baribaud, I., Hou, W., Zou, C., Geraghty, R. J., Spear, P. G., Eisen-
berg, R. J., and Cohen, G. H. (1999). The first immunoglobulin-like
domain of HveC is sufficient to bind herpes simplex virus gD with full
affinity, while the third domain is involved in oligomerization of HveC.
J. Virol. 73(10), 8127–8137.
Ligas, M. W., and Johnson, D. C. (1988). A herpes simplex virus mutant
in which glycoprotein D sequences are replaced by beta-galactosi-
dase sequences binds to but is unable to penetrate into cells. J. Virol.
62(5), 1486–1494.
Lopez, M., Cocchi, F., Menotti, L., Avitabile, E., Dubreuil, P., and Cam-
padelli-Fiume, G. (2000). Nectin2a (PRR2a or HveB) and nectin2d are
low-efficiency mediators for entry of herpes simplex virus mutants
carrying the Leu25Pro substitution in glycoprotein D. J. Virol. 74(3),
1267–1274.
Lopez, M., Eberle´, F., Mattei, M. G., Gabert, J., Birg, F., Bardin, F., Maroc,
C., and Dubreuil, P. (1995). Complementary DNA characterization and
chromosomal localization of a human gene related to the poliovirus
receptor-encoding gene. Gene 155(2), 261–265.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951).
Protein measurement with the Folin phenol reagent. J. Biol. Chem.
193, 365–375.
Meignier, B., Longnecker, R., Mavromara-Nazos, P., Sears, A. E., and
Roizman, B. (1988). Virulence of and establishment of latency by
genetically engineered deletion mutants of herpes simplex virus 1.
Virology 162(1), 251–254.
Menotti, L., Lopez, M., Avitabile, E., Stefan, A., Cocchi, F., Adelaide, J.,
Lecocq, E., Dubreuil, P., and Campadelli Fiume, G. (2000). The murine
homolog of human-Nectin1d serves as a species non-specific me-
diator for entry of human and animal aherpesviruses in a pathway
independent of a detectable binding to gD. Proc. Natl. Acad. Sci. USA
97(9), 4867–4872.
ontgomery, R. I., Warner, M. S., Lum, B. J., and Spear, P. G. (1996).
Herpes simplex virus-1 entry into cells mediated by a novel member
of the TNF/NGF receptor family. Cell 87(3), 427–436.
Nicola, A. V., Peng, C., Lou, H., Cohen, G. H., and Eisenberg, R. J. (1997).
Antigenic structure of soluble herpes simplex virus (HSV) glycopro-
tein D correlates with inhibition of HSV infection. J. Virol. 71(4),
2940–2946.
Nixdorf, R., Schmidt, J., Karger, A., and Mettenleiter, T. C. (1999). Infec-
PR
S
S
S
S
S
S
S
S
W
W
W
266 MENOTTI ET AL.tion of Chinese hamster ovary cells by pseudorabies virus. J. Virol.
73(10), 8019–8026.
Noble, A. G., Lee, G. T., Sprague, R., Parish, M. L., and Spear, P. G.
(1983). Anti-gD monoclonal antibodies inhibit cell fusion induced by
herpes simplex virus type 1. Virology 129(1), 218–224.
Pereira, L., Dondero, D., Norrild, B., and Roizman, B. (1981). Differential
immunologic reactivity and processing of glycoproteins gA and gB of
herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells.
Proc. Natl. Acad. Sci. USA 78(8), 5202–5206.
Pereira, L., Dondero, D. V., Gallo, D., Devlin, V., and Woodie, J. D. (1982).
Serological analysis of herpes simplex virus types 1 and 2 with
monoclonal antibodies. Infect. Immun. 35(1), 363–367.
ereira, L., Klassen, T., and Baringer, J. R. (1980). Type-common and
type-specific monoclonal antibody to herpes simplex virus type 1.
Infect. Immun. 29(2), 724–732.
eymond, N., Borg, J., Lecocq, E., Adelaide, J., Campadelli-Fiume, G.,
Dubreuil, P., and Lopez, M. (2000). Human nectin3/PRR3: A novel
member of the PVR/PRR/nectin family that interacts with afadin.
Gene 255(2), 347–355.
abbioni, S., Negrini, M., Rimessi, P., Manservigi, R., and Barbanti-
Brodano, G. (1995). A BK virus episomal vector for constitutive high
expression of exogenous cDNAs in human cells. Arch. Virol. 140(2),
335–339.
chmidt, J., Klupp, B. G., Karger, A., and Mettenleiter, T. C. (1994).
Adaptability in herpesviruses: Glycoprotein D-independent infectivity
of pseudorabies virus. J. Virol. 71, 17–24.
chroder, C., Linde, G., Fehler, F., and Keil, G. M. (1997). From essential
to beneficial: Glycoprotein D loses importance for replication of
bovine herpesvirus 1 in cell culture. J. Virol. 71(1), 25–33.erafini-Cessi, F., Dall’Olio, F., Malagolini, N., Pereira, L., and Cam-
padelli-Fiume, G. (1988). Comparative study on O-linked oligosac-charides of glycoprotein D of herpes simplex virus types 1 and 2.
J. Gen. Virol. 69(Pt. 4), 869–877.
howalter, S. D., Zweig, M., and Hampar, B. (1981). Monoclonal anti-
bodies to herpes simplex virus type 1 proteins, including the imme-
diate-early protein ICP 4. Infect. Immun. 34(3), 684–692.
hukla, D., Dal Canto, M. C., Rowe, C. L., and Spear, P. G. (2000).
Striking similarity of murine Nectin-1alpha to human Nectin-1alpha
(HveC) in sequence and activity as a glycoprotein D receptor for
alphaherpesvirus entry. J. Virol. 74(24), 11773–11781.
hukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D.,
Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., and Spear, P. G.
(1999). A novel role for 3-O-sulfated heparan sulfate in herpes sim-
plex virus 1 entry. Cell 99(1), 13–22.
pear, P. G., Eisenberg, R. J., and Cohen, G. H. (2000). Three classes of
cell surface receptors for alphaherpesvirus entry. Virology 275(1),
1–8.
arner, M. S., Geraghty, R. J., Martinez, W. M., Montgomery, R. I.,
Whitbeck, J. C., Xu, R., Eisenberg, R. J., Cohen, G. H., and Spear, P. G.
(1998). A cell surface protein with herpesvirus entry activity (HveB)
confers susceptibility to infection by mutants of herpes simplex virus
type 1, herpes simplex virus type 2, and pseudorabies virus. Virology
246(1), 179–189.
hitbeck, J. C., Muggeridge, M. I., Rux, A. H., Hou, W., Krummenacher,
C., Lou, H., van Geelen, A., Eisenberg, R. J., and Cohen, G. H. (1999).
The major neutralizing antigenic site on herpes simplex virus glyco-
protein D overlaps a receptor-binding domain. J. Virol. 73(12), 9879–
9890.
illis, S. H., Rux, A. H., Peng, C., Whitbeck, J. C., Nicola, A. V., Lou, H.,
Hou, W., Salvador, L., Eisenberg, R. J., and Cohen, G. H. (1998).
Examination of the kinetics of herpes simplex virus glycoprotein D
binding to the herpesvirus entry mediator, using surface plasmon
resonance. J. Virol. 72(7), 5937–5947.
